Tech Company Financing Transactions
Neurolief Funding Round
On 3/26/2026, Neurolief announced $6 million in investment from BrainsWay.
Transaction Overview
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10211 W. Sample Rd. 109
Coral Springs, FL 33065
USA
Coral Springs, FL 33065
USA
Phone
Website
Email Address
Overview
At Neurolief, we're committed to bringing relief to people suffering from mental health and neurological disorders. As pioneers in mental healthcare, we've developed the world's first and only non-invasive, multi-channel brain neuromodulation system. This system concurrently neuromodulates major neural pathways in the head, thereby affecting brain regions involved in the regulation of mood and pain. Neurolief technology is approved by the FDA (USA), CE (Europe), and PMDA (Japan) for the treatment of migraine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Drees
Chief Financial Officer
Anthony Borowicz
Chief Marketing Officer
Owen Muir
Chief Technical Officer
Amit Dar
VP - Bus. Development
Steve Beller
VP - R & D
Ron Belson
VP - Regulatory Affairs
Dganit Litinsky
Browse more venture capital transactions:
Prev: 3/26/2026: Sous venture capital transaction
Next: 3/26/2026: Zentro Internet venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs